News

HHS pointed the DEA to a Florida 7-OH rule that Florida had already replaced

The federal 7-OH proposal uses the two numbers in a Florida rule HHS described. Florida had replaced that rule in August, changing what they count. Its label rule expires on 22 November.

Sources last verified: 7 November 2026. This report describes what the documents said on that date. A rule can take effect, expire, be amended or be challenged afterwards. If you are relying on this for a decision, check the primary sources at the foot of the article.

The US Drug Enforcement Administration (DEA) said in a notice of intent on 14 October 2026 that it proposes to control concentrated 7-hydroxymitragynine (7-OH, a minor kratom alkaloid) using the same two numbers as a Florida rule. It did so after a letter from the Department of Health and Human Services (HHS) pointed to Florida as a working example.

The rule that letter describes was no longer the rule in force. HHS set out a test covering seven alkaloids combined, under the number 2ER26-1. Florida had replaced 2ER26-1 on 18 August 2026 with 2ER26-2, whose limit and ratio name 7-OH alone. The numbers survived that change, 1 milligram per gram and 100 to 1. What changed is what they count.

This article describes the position as of 7 November 2026. Four instruments matter, and they stand in different places:

  • Florida Emergency Rule 2ER26-2 is in force. The Florida Administrative Register gives it an effective date of 18 August 2026 and an expiration date of 30 June 2027.
  • Florida Emergency Rule 5KER26-11, the label rule, is in force. The Register gives it an expiration date of 22 November 2026.
  • Florida Rule 5K-4.030 is permanent. It took effect on 10 January 2024 and carries the permit and age-verification requirements.
  • The DEA’s 7-OH notice is proposed, not in force. It says an order “will be published in the Federal Register on or after November 13, 2026”. We found no such order in the Federal Register through 6 November.

What Florida’s rule says

2ER26-2 was made by Attorney General James Uthmeier under section 893.035 of the Florida Statutes, which lets the Attorney General place a substance in Schedule I temporarily to avoid an imminent hazard to public safety. Schedule I is the most restrictive class of controlled substance. Under section 893.035(8), a substance added this way is deemed part of the schedule even though the printed section 893.03 does not list it.

The rule does two things. It adds 7-acetoxymitragynine, MGM-15 and MGM-16 to Schedule I without any threshold. And it adds 7-OH subject to two conditions:

  • “No product shall have an amount of 7-hydroxymitragynine greater than” 1 milligram per gram for solid or powdered products, or 1 milligram per millilitre for liquids.
  • “Any product containing 7-hydroxymitragynine must have at least 100 parts mitragynine for every one part of 7-hydroxymitragynine by mass.”

Mitragynine is the main alkaloid in kratom leaf. Florida does not schedule it. It serves only as the yardstick for the ratio. Our Florida page sets out the rest of the state’s kratom law.

The rule’s reach may be wider than its list. It does not name mitragynine pseudoindoxyl. But section 893.03(1)(a), the paragraph it adds to, covers listed substances “including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation”. The state agriculture department’s first two label rules said isomers of 7-OH include pseudoindoxyl. Both have ended, and both were food-labelling rules rather than readings of the drug statute. Against that, the June rule listed pseudoindoxyl separately from 7-OH, the department’s third label rule did the same, and the label rule now in force does not mention it. Whether the August rule reaches it is a legal question we are not going to answer.

How the rule got here

The first versions used different numbers. The chain starts with 2ER25-1, effective 12 August 2025, whose title on the Register scheduled 7-OH “concentrated at a level above 1 percent by total weight”. That is 10 milligrams per gram. A week later 2ER25-2, effective 19 August, superseded it with “concentrated at a level above four hundred parts per million on a dry-weight basis”, which is 0.4 milligrams per gram. The present limit, 1 milligram per gram, is two and a half times the second figure and a tenth of the first, and it names no dry-weight basis. The Register records 2ER25-3, which a Senate staff analysis says updated the findings and did not change the scheduling, as filed on 8 December 2025 with an expiration date of 30 June 2026.

A bill would have written 7-OH into statute, and the enacted version does not. SB 432, filed for the 2026 session, would have added 7-OH to section 893.03 by name. On 24 February 2026 the Senate Committee on Fiscal Policy adopted a substitute, and the staff analysis records that it “removes the proposed addition of 7-Hydroxymitragynine to the Schedule I controlled substances list”. The analysis does not say why. The bill became chapter 2026-148, Laws of Florida, which amends section 893.03 on other subjects. Its text contains no reference to 7-OH or kratom.

That matters because of section 893.035(9). The Attorney General reports these rules to the Legislature by 1 March each year, and each reported rule “shall expire on the following June 30 unless the Legislature adopts the provisions thereof as an amendment to this chapter.”

A new rule followed. 2ER26-1 scheduled seven compounds and introduced the 1 milligram limit and the 100-to-1 ratio. Its dates depend on where you read them. The Attorney General’s copy gives an effective date of 22 June 2026. The Register records it as filed on 23 June and effective on 1 July 2026, its notice of the rule prints the same effective date, and a later notice from the state agriculture department also dates it 1 July. On the Register’s own dates there is no gap, because 2ER25-3 carries an expiration date of 30 June. But a second department notice says the Attorney General repealed 2ER25-3 on 23 June, and his copy of the new rule says it supersedes 2ER25-3. If the repeal took effect on 23 June and the new rule on 1 July, those records leave 23 to 30 June unexplained. We report them and cannot reconcile them.

Then the rule moved in two directions. 2ER26-2 superseded it on 18 August. Mitragynine pseudoindoxyl, 9-hydroxycorynantheidine and 10-hydroxymitragynine are named in the June rule and not in the August one, and the limit and the ratio now name 7-OH alone. On its face, that part loosened, subject to the isomer question above. The opposite happened to 7-acetoxymitragynine, MGM-15 and MGM-16. The June rule controlled them above a threshold, and the August rule places them in Schedule I in any amount. Neither the rule nor its Register notice gives a reason. The notice says the Attorney General’s written findings are available from his office, and we have not read those. It also says he “will ask the Florida Legislature to memorialize this action through legislation in its 2027 legislative session.”

What HHS described, and what Florida had

The HHS letter is dated 8 October 2026, seven weeks after the change. It says a strategy “suggested in public comments” has been “implemented under Florida state rulemaking”, and describes a limit of “1 mg combined mass of 7-OH and other specified alkaloids” with a matching 100-to-1 ratio. It identifies the rule as 2ER26-1, and links to the Attorney General’s June copy. A footnote to that reference reads “Effective date of August 18, 2026”. That is the date of the rule that replaced it. It is also a date the Register’s own page for 2ER26-1 displays, beside a history note reading “Superseded by 2ER26-2, 8-18-26”, which may be where the footnote’s date came from.

The letter then calls its own recommendation “consistent with Florida state law, where any product containing any amount of the specified alkaloids (7-OH, MGPI, and others) must contain at least 100 times more mitragynine”. MGPI is mitragynine pseudoindoxyl. Since 18 August the Florida rule has not named it.

2ER26-1 (the rule HHS described)2ER26-2 (Florida’s rule now)DEA notice, 91 FR 65370
StatusSuperseded 18 August 2026In forceProposed
What the 1 mg limit countsSeven alkaloids, combined7-OH7-OH and pseudoindoxyl, alone or combined
What the 100-to-1 ratio countsSeven alkaloids, combined7-OH7-OH and pseudoindoxyl, alone or combined
PseudoindoxylNamed, inside the testNot namedNamed, inside the test
7-acetoxymitragynine, MGM-15, MGM-16Inside the threshold testSchedule I in any amountNot placed by this notice

The DEA’s notice does not rely on Florida in terms. It names the state once, in a list of states with kratom consumer-protection laws. The reasoning for the threshold is in the HHS letter, which the DEA placed in its docket.

The letter’s case for the test does not rest on Florida alone. It relays Food and Drug Administration (FDA) analysis of alkaloid content in kratom and of animal studies, which our report on the DEA notice covers. HHS also tried the Florida criteria against product results. It says they “would appear to establish Schedule I status for various intentionally enhanced products, and rarely establish a product as Schedule I for products purported to be unaltered chemically from natural kratom”, and that this “is based on data and studies for which FDA has not had direct access”. The DEA adds that “neither HHS nor DEA has made a finding that these substances are safe to use at below-threshold levels.” We do not know whether HHS knew of the August change, or whether knowing would have altered anything. The letter does not address it, and we have seen no statement from HHS on the point.

The label rule’s clock

5KER26-11, from the Florida Department of Agriculture and Consumer Services, requires a kratom product to declare its 7-OH concentration and its ratio of mitragynine to 7-OH, with 7-OH’s isomers, esters, ethers and salts counted in. The figures can be on the package or behind a permanently affixed QR code. The rule rests on different law from the Attorney General’s rule, and the difference is why it expires first.

Section 893.035(7)(b) exempts the Attorney General’s scheduling rules from the ordinary limit on emergency rules. The department has no such exemption. Section 120.54(4)(c) says an emergency rule “may not be effective for a period longer than 90 days and may not be renewable”, with exceptions for an agency that has started ordinary rulemaking on the subject and has a challenge pending or is awaiting legislative ratification.

The department has issued four kratom label rules in 2026, under four numbers:

RuleIn force fromHow it ended
5KER26-118 March 2026Register expiration date 16 June 2026
5KER26-817 June 2026Repealed 1 July 2026, because the Attorney General had repealed 2ER25-3, the department said
5KER26-91 July 2026Repealed 6 August 2026, because the DEA’s July notice used different concentrations, the department said
5KER26-1124 August 2026Register expiration date 22 November 2026

The Register numbers them as four rules. 5KER26-8 began the day after 5KER26-1’s expiration date and kept its requirement of a figure in parts per million on a dry-weight basis. Whether that sits within the ban on renewal in section 120.54(4)(c) is a legal question we have not answered. The requirement changed with the later rules: 5KER26-11 requires milligrams per gram or per millilitre plus the alkaloid ratio. We found no label rule in force between 6 and 24 August.

The department’s reason for the August repeal is worth reading beside the HHS letter. Repealing 5KER26-9 on 6 August, it said it intended to wait, because the DEA’s July numbers differed from the state’s. It did not wait long: 5KER26-11 came on 24 August, six days after 2ER26-2 and seven weeks before the DEA’s October notice, which then used the state’s numbers.

The Register’s history for permanent Rule 5K-4.030 shows no entry after the rule took effect in January 2024, so we found no notice starting ordinary rulemaking under that number. A notice under a different number could exist, and we could not run the Register’s full-text search. We cannot say what the department will do on or before 22 November.

If the rule lapses, the label duty it created lapses with it, including its statement that controlled substances are adulterants under section 500.10. Other law stays. Rule 5K-4.030 is permanent, and when it repealed 5KER26-8 the department said it would continue to enforce what it called its “adulteration statute, section 500.12” for products with a dangerous or deleterious amount of 7-OH. The Schedule I limits are in the Attorney General’s rule. The Register gives it an expiration date of 30 June 2027, unless it is repealed, invalidated or superseded first or the Legislature adopts it under section 893.035(9). 2ER25-1, 2ER25-2 and 2ER26-1 were each superseded.

The states we read did not copy the ratio

Five states’ instruments were read for this article. Other states have acted and were not read, so this is not a survey. Among these five, only Florida uses a ratio.

StateInstrumentWhat it does to 7-OHStatus
FloridaEmergency Rule 2ER26-2Schedule I above 1 mg per gram or millilitre, or below 100-to-1In force; Register expiration 30 June 2027
North DakotaHouse Bill 1628Schedule I above 0.05 per cent by dry weight in botanical material; above 0.05 per cent or 1 mg in the article for synthetic or further-processed products; separate licensing regime for leafFiled 4 September 2026, effective on filing
OhioRule 4729:9-1-01.1Schedule I with no threshold, among “mitragynine-related compounds”; natural leaf exceptedEffective 19 May 2026
Massachusetts105 CMR 726.000The whole plant in Schedule 1, no thresholdEffective 28 August 2026, for one year
LouisianaAct 41 of 2025; emergency rule, LAC 46:LIII.2704Act 41 puts 7-OH and mitragynine in Schedule I; the emergency rule adds pseudoindoxyl, MGM-15 and MGM-16Emergency rule, announced 19 October 2026; the copy we read prints no effective date

North Dakota’s numbers are the ones the DEA proposed in July. The state Board of Pharmacy put them in an emergency rule effective 5 August 2026, and the Legislature then wrote them into statute at a special session. The DEA’s October notice says the July notice is being withdrawn, though we have not found the withdrawal document in the Federal Register. So a state statute carries numbers from a federal proposal the DEA says it is replacing. Neither federal notice is in force.

North Dakota also moved in the opposite direction from Massachusetts. Governor Armstrong’s executive order of 3 August banned all kratom in the state, and he rescinded it on signing HB 1628, which licenses leaf sales to people aged 21 and over. Massachusetts scheduled the whole plant and has left it there. Our explainer on state kratom acts covers the consumer-protection laws separately.

What a dropped substance does not mean

Mitragynine pseudoindoxyl, missing from Florida’s August rule, has not been cleared. The isomer question above is one reason. Federal law is the other, because it applies in Florida as well. Pseudoindoxyl, MGM-15 and MGM-16 have been in federal Schedule I in any amount since 26 August 2026 under a temporary order, 91 FR 54948. That order was still the position on 7 November. The DEA’s October notice, 91 FR 65370, would change how pseudoindoxyl is treated, and it has not taken effect. A companion notice, 91 FR 65381, gives notice of a new temporary order that would keep MGM-15 and MGM-16 in Schedule I without change, no earlier than 13 November 2026. The August order stays in effect until then. That notice refers to an HHS letter dated 6 October relating only to pseudoindoxyl. 91 FR 65370 cites one dated 8 October, which is the date on the letter we read, and we did not find a 6 October letter in the docket we opened.

If the order matches the notice, the two tests would differ: pseudoindoxyl would count toward the federal limit and is not named in Florida’s.

The other two compounds dropped in August, 9-hydroxycorynantheidine and 10-hydroxymitragynine, are not named in any of those three federal documents. We have not shown that either reason above reaches them, and we have not assessed the federal analogue law or any other route, so we draw no conclusion about them either way.

The HHS letter quotes a Department of Justice press release saying the DEA intends to exercise enforcement discretion over incidental trace amounts of pseudoindoxyl in a product otherwise consistent with botanical kratom. That is a stated intention in a press release, and it is not in the order.

What is not known

Whether the Florida Legislature will adopt the Attorney General’s rule in 2027. Whether the DEA’s order, when it comes, will match its notice. Whether the department will issue a fifth label rule, start ordinary rulemaking, or let the requirement end. We will update this article when any of those documents exists.

Sources

  1. Emergency Rule 2ER26-2, addition of 7-hydroxymitragynine, 7-acetoxymitragynine, MGM-15 and MGM-16 to Schedule I, subsection 893.03(1)(a), Office of the Attorney General of Florida, Florida Administrative Register, 18 Aug 2026
  2. Notice of Emergency Rule 2ER26-2, Florida Administrative Register Vol. 52/162, Florida Department of Legal Affairs, Florida Administrative Register, 20 Aug 2026
  3. Final adopted version of Emergency Rule 2ER26-2 (rule file, effective and expiration dates), Florida Administrative Code and Register
  4. Emergency Rule 2ER26-1, Register record, Office of the Attorney General of Florida, Florida Administrative Register
  5. Final adopted version of Emergency Rule 2ER26-1 (rule file, effective and expiration dates), Florida Administrative Code and Register
  6. Emergency Rule 2ER26-1, the Attorney General's copy (scan, read by optical character recognition), Office of the Attorney General of Florida, 22 Jun 2026
  7. Notice of Emergency Rule 2ER26-1, Florida Administrative Register, Florida Department of Legal Affairs, Florida Administrative Register
  8. Emergency Rule 2ER25-1, Register record, Office of the Attorney General of Florida, Florida Administrative Register, 12 Aug 2025
  9. Emergency Rule 2ER25-2, Register record, Office of the Attorney General of Florida, Florida Administrative Register, 19 Aug 2025
  10. Final adopted version of Emergency Rule 2ER25-3 (rule file, effective and expiration dates), Florida Administrative Code and Register
  11. Emergency Rule 5KER26-11, Requirement to Label Kratom Products, Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 24 Aug 2026
  12. Final adopted version of Emergency Rule 5KER26-11 (rule file, effective and expiration dates), Florida Administrative Code and Register
  13. Rule Chapter 5KER26, Emergency Rule for Year 2026 (list of rules), Florida Administrative Code and Register
  14. Emergency Rule 5KER26-1, Requirement to Label the Concentration of 7-Hydroxymitragynine on Kratom Products, Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 18 Mar 2026
  15. Emergency Rule 5KER26-8, Requirement to Label the Concentration of 7-Hydroxymitragynine on Kratom Products (Repealed), Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 17 Jun 2026
  16. Emergency Rule 5KER26-9, Requirement to Label Kratom Products (Repealed), Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 1 Jul 2026
  17. Notice of Emergency Rule 5KER26-8, Florida Administrative Register Vol. 52/127, Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 1 Jul 2026
  18. Notice of Emergency Rule 5KER26-9, Florida Administrative Register Vol. 52/153, Florida Department of Agriculture and Consumer Services, Florida Administrative Register, 7 Aug 2026
  19. Rule 5K-4.030, F.A.C., Kratom Products, Florida Department of Agriculture and Consumer Services, Florida Administrative Code, 10 Jan 2024
  20. Florida Statutes § 893.035, Control of new substances; findings of fact; delegation of authority to Attorney General (2026 Florida Statutes), The Florida Legislature
  21. Florida Statutes § 893.03, Standards and schedules (2026 Florida Statutes), The Florida Legislature
  22. Florida Statutes § 120.54, Rulemaking (2026 Florida Statutes), The Florida Legislature
  23. CS/SB 432 (2026), Intoxicating Substances, bill record, The Florida Senate
  24. SB 432 (2026), as filed, The Florida Senate
  25. Bill Analysis and Fiscal Impact Statement, SB 432, Committee on Criminal Justice, 9 January 2026, The Florida Senate, 9 Jan 2026
  26. Bill Analysis and Fiscal Impact Statement, CS/SB 432, Committee on Fiscal Policy, 24 February 2026, The Florida Senate, 24 Feb 2026
  27. Chapter 2026-148, Laws of Florida (Committee Substitute for Senate Bill No. 432), Florida Department of State
  28. 261008 ASH memo to DEA- Recommendation on 7-OH thresholding- 712892 ASH signed- UPDATED (letter of the Assistant Secretary for Health to the DEA Administrator, 8 October 2026), Docket DEA-2026-1190, US Department of Health and Human Services, Office of the Assistant Secretary for Health, via Regulations.gov, 8 Oct 2026
  29. Schedules of Controlled Substances: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I (Docket No. DEA-1570), 91 FR 65370, Federal Register / Drug Enforcement Administration, 14 Oct 2026
  30. Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I (Docket No. DEA-1644), 91 FR 65381, Federal Register / Drug Enforcement Administration, 14 Oct 2026
  31. Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (Docket No. DEA-1644), 91 FR 54948, Federal Register / Drug Enforcement Administration, 26 Aug 2026
  32. Federal Register API: documents of the Drug Enforcement Administration published from 10 October 2026, Federal Register / Office of the Federal Register
  33. House Bill No. 1628, enrolled, Sixty-ninth Legislative Assembly of North Dakota, Special Session commencing 2 September 2026, North Dakota Legislative Assembly
  34. House Bill 1628 actions (signed by the Governor and filed with the Secretary of State, 4 September), North Dakota Legislative Assembly
  35. Executive Order 2026-04, Office of the Governor of North Dakota, 3 Aug 2026
  36. UPDATED: Armstrong signs bill banning synthetic kratom, restricting natural kratom to 21 and older, Office of the Governor of North Dakota, 4 Sept 2026
  37. Emergency Rule Changes to NDAC 61-13-01-03, North Dakota Board of Pharmacy, 5 Aug 2026
  38. Ohio Administrative Code Rule 4729:9-1-01.1, Mitragynine-Related Compounds, Ohio Legislative Service Commission / Ohio Board of Pharmacy, 19 May 2026
  39. 105 CMR 726.000: Temporary placement of Kratom in schedule 1 pursuant to M.G.L. c. 94C, § 2A, Massachusetts Department of Public Health
  40. Act No. 41, 2025 Regular Session (Senate Bill No. 154), Louisiana State Legislature
  41. Declaration of Emergency, Added Controlled Dangerous Substances (LAC 46:LIII.2704), Louisiana Department of Health, Office of Public Health
  42. LDH adds three substances to Schedule I controlled substances list, Louisiana Department of Health, 19 Oct 2026